"L’Hôpital de La Tour est un établissement de soins aigus de haut niveau, privé, indépendant et à dimension humaine."

During the past decade, Hopital de la Tour conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital de la Tour" #1 sponsor was "La Tour Hospital" with 6 trials, followed by "Biosensors Europe SA" with 2 trials sponsored, "Cordis Corporation" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Adrien Schwitzguebel" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de la Tour" #1 collaborator was "European Cardiovascular Research Center" with 1 trials as a collaborator, "Rive Droite SA" with 1 trials as a collaborator and "Swiss Shoulder and Elbow Surgeons Expert Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de la Tour" are "Coronary Artery Disease" (6 trials), "Acromioclavicular Joint Dislocation" (1 trials), "Acute Coronary Syndrome" (1 trials), "Arthritis" (1 trials) and "Arthritis Shoulder" (1 trials). Many other conditions were trialed in "Hopital de la Tour" in a lesser frequency.

Most popular intervention types in "Hopital de la Tour" are "Device" (8 trials), "Procedure" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abluminus DES+ Sirolimus Eluting Stent System (SES)" (1 trials), "Acromioplasty with planning" (1 trials), "Acromioplasty without planning" (1 trials), "Biofreedom™ Drug Coated Stent (DCS)" (1 trials) and "Boston Scientific Systems" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de la Tour" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Hopital de la Tour". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hopital de la Tour, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de la Tour, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".